Molecular biology of lung cancer-a review

Dinesh Pendharkar1, B V Ausekar2, Sumant Gupta3

  • 1Asian Institute of Oncology, S. L. Raheja Hospital, Mahim, Mumbai, 400016 India.

Insights

Lung cancer incidence is rising in Indian males, often diagnosed late. This review focuses on key molecular targets, like receptor tyrosine kinases, with therapeutic implications for improved lung cancer survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a leading and increasing cancer in Indian males.
  • Diagnosis often occurs at late stages, leading to poor survival rates.
  • Current research emphasizes molecular profiling for targeted therapies.

Purpose of the Study:

  • To review important molecular profiles of lung cancer.
  • To highlight receptor tyrosine kinases as key molecular markers and therapeutic targets.
  • To discuss molecular alterations driving lung cancer with therapeutic implications.

Main Methods:

  • Literature review of current oncology research.
  • Focus on molecular profiling and receptor tyrosine kinases.
  • Analysis of gene mutations and amplifications in lung cancer.

Main Results:

  • Receptor tyrosine kinases (RTKs) are significant molecular targets in lung cancer.
  • Mutations and amplifications in RTKs are common.
  • Therapeutic options are available for targets like EGFR, ALK, MET, and KRAS.

Conclusions:

  • Molecular profiling is crucial for understanding and treating lung cancer.
  • Targeted therapies based on molecular alterations offer improved treatment strategies.
  • Further research into molecular profiles can enhance patient survival in lung cancer.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K